共 50 条
- [21] A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (natalizumab) in maintaining clinical response and remission in Crohn's disease (ENACT-2)GASTROENTEROLOGY, 2004, 127 (01) : 332 - 332Sandborn, WColombel, JFEnns, RFeagan, BHanauer, SLawrance, IPanaccione, RSanders, MSchreiber, STargan, SVan Deventer, SRutgeerts, P
- [22] Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 studyLANCET, 2017, 389 (10080): : 1699 - 1709Feagan, Brian G.Sandborn, William J.D'Haens, GeertPanes, JulianKaser, ArthurFerrante, MarcLouis, EdouardFranchimont, DenisDewit, OlivierSeidler, UrsulaKim, Kyung-JoNeurath, Markus F.Schreiber, StefanScholl, PaulPamulapati, ChandrasenaLalovic, BojanVisvanathan, SudhaPadula, Steven J.Herichova, IvonaSoaita, AdinaHall, David B.Bocher, Wulf O.
- [23] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821Chowla, Navreet M.Tariq, RaseenAggarwal, ManikLoftus, Edward V.
- [24] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with mild or moderate asthmaEUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A95 - A96Williams, S. P.Mcardle, J. R.Colice, G.Lankford, A.Kajdasz, D. K.Reed, C. R.
- [25] Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical TrialJAMA DERMATOLOGY, 2021, 157 (11) : 1279 - 1288Glatt, SophieJemec, Gregor B. E.Forman, SethSayed, ChristopherSchmieder, GeorgeWeisman, JamieRolleri, RobertSeegobin, SethBaeten, DominiqueIonescu, LucianZouboulis, Christos C.Shaw, Stevan
- [26] A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's diseaseGASTROENTEROLOGY, 2004, 127 (01) : 332 - 332Hanauer, SLukás, MMacIntosh, DRutgeerts, PSandborn, WPollack, P
- [27] Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled studyALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 377 - 383Jorgensen, S. P.Agnholt, J.Glerup, H.Lyhne, S.Villadsen, G. E.Hvas, C. L.Bartels, L. E.Kelsen, J.Christensen, L. A.Dahlerup, J. F.
- [28] Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled studyCritical Care, 2 (Suppl 1):KH StaubachJ SchröderP ZabelF Stüber
- [29] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled studyNEUROLOGY, 2009, 72 (09) : 806 - 812Goodman, A. D.Rossman, H.Bar-Or, A.Miller, A.Miller, D. H.Schmierer, K.Lublin, F.Khan, O.Bormann, N. M.Yang, M.Panzara, M. A.Sandrock, A. W.
- [30] A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington DiseaseJAMA NEUROLOGY, 2013, 70 (01) : 25 - 33Kieburtz, KarlLandwehrmeyer, Georg B.Cudkowicz, MeritDorsey, E. RayFeigin, AndrewHunt, VictoriaKayson, EliseMcDermott, MichaelNoonberg, SarahSeitz, WendySoliveri, PaolaWalker, FrancisBurgunder, Jean-MarcRomero, IreneMagara, AnoukStebler, YanikRickards, HughWright, JanDe Souza, JennyBarker, Roger A.Mason, SarahDi Pietro, AnnaGoodman, AnnaO'Keeffe, DeidreLanglois, MelanieFerland, GermainVerret, LouisChouinard, SylvainParis, SuzanneLePage, ChristianeNemeth, Andrea H.Merritt, ClaireCox, CarolineAstbury, ThereseMurphy, SarahAhmed, AnwarSt Marie, PatriciaBerila, Rose AnneKubu, CynthiaSegro, VickiKumar, RajeevErickson, DianeSchneiders, JayFrucht, StevenWasserman, PaulaMoskowitz, CarolScott, BurtonPerry-Trice, PeggyWyne, SarahSoliveri, Paola